These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7101877)

  • 21. [Acute phase reaction in non-transmural myocardial infarction].
    Adamska-Dyniewska H; Tkaczewski W; Kawecka M; Kowalczyk L; Gajewska B
    Pol Tyg Lek; 1983 Jul 11-18; 38(28-29):873-6. PubMed ID: 6657526
    [No Abstract]   [Full Text] [Related]  

  • 22. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass).
    Jurlander B; Clemmensen P; Wagner GS; Grande P
    Eur Heart J; 2000 Mar; 21(5):382-9. PubMed ID: 10666352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum CPK activity in the diagnosis of acute myocardial infarction.
    Lewis MJ
    Pa Med; 1967 Apr; 70(4):77-80. PubMed ID: 6041617
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thrombolytic treatment of myocardial infarct].
    Weller P; Leeder U
    Z Gesamte Inn Med; 1970 May; 25(10):441-4. PubMed ID: 5523560
    [No Abstract]   [Full Text] [Related]  

  • 25. [Platelet enzymes in acute myocardial infarct].
    Moronescu M; Dumitriu I; Vasile I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(5):421-6. PubMed ID: 6134318
    [No Abstract]   [Full Text] [Related]  

  • 26. [Activity of aspartate- and alanine aminotransferases, creatine kinase and arginase after implantation of an artificial pacemaker].
    Dosiak J; Wiernek I; Kocot A
    Pol Tyg Lek; 1981 Apr; 36(14):481-3. PubMed ID: 7267418
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fibrinolytic therapy in acute myocardial infarct].
    Burkart F; Duckert F; Straub PW; Frick PG; Schweizer W; Koller F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1814-6. PubMed ID: 4588618
    [No Abstract]   [Full Text] [Related]  

  • 28. CK and ASAT: comparative evaluation as prognostic indicator in acute myocardial infarction.
    Saxena KK; Gupta B; Gopal R; Srivastava SS; Prasad DN
    Indian J Chest Dis Allied Sci; 1985; 27(3):159-63. PubMed ID: 3837766
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrocardiographic localization of myocardial infarct and the activity of various blood serum enzymes in the acute stage of the disease].
    Stasiński T; Walczak-Mińko R; Kostka-Wach M; Biryńczyk J; Kawczyńska D; Wróz M
    Pol Arch Med Wewn; 1980 Nov; 64(5):443-8. PubMed ID: 7220362
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: Assessing myocardial damage in acute infarcts.
    Maroko PR
    N Engl J Med; 1974 Jan; 290(3):158-9. PubMed ID: 4808586
    [No Abstract]   [Full Text] [Related]  

  • 31. Myocardial-infarct extension detected by precordial ST-segment mapping.
    Reid PR; Taylor DR; Kelly DT; Weisfeldt ML; Humphries JO; Ross RS; Pitt B
    N Engl J Med; 1974 Jan; 290(3):123-8. PubMed ID: 4808584
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma fibrinogen and serum enzymes: relative significance as prognostic indicator in acute myocardial infarction.
    Saxena KK; Gupta B; Gopal R; Srivastava SS; Singh RC; Kulshrestha VK; Prasad DN
    J Assoc Physicians India; 1986 Sep; 34(9):641-2. PubMed ID: 3793700
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum "cardiac" enzyme levels after laparotomy. Of value in the diagnosis of postoperative myocardial infarction?
    Irving AD; Kennedy D
    J R Coll Surg Edinb; 1984 Jul; 29(4):252-3. PubMed ID: 6481677
    [No Abstract]   [Full Text] [Related]  

  • 34. [Do creatine kinase-B (CK-B) and myoglobin determinations have any advantages over SGOT in the routine diagnosis of myocardial infarction].
    von der Lippe G; Stensland E; Romslo I
    Tidsskr Nor Laegeforen; 1981 Jan; 101(1B):93-6. PubMed ID: 7456086
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mapping of inferior wall myocardial infarcts--a new method].
    Silva JA; Lilenbaum RC; Lima Rde S; Xavier SS; Torres CA; Pedrosa RC
    Arq Bras Cardiol; 1987 Nov; 49(5):279-82. PubMed ID: 3454149
    [No Abstract]   [Full Text] [Related]  

  • 36. [Screening and rapid tests in heart diseases and cardiovascular shock].
    Prellwitz W; Neumeier D
    Internist (Berl); 1976 Sep; 17(9):436-44. PubMed ID: 786933
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prospects for the use of myoglobin radioimmunoassay].
    Bondareva ZG; Bredikhin AV; Matveev LE
    Med Radiol (Mosk); 1984 Nov; 29(11):19-21. PubMed ID: 6503644
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rationalization of serial determinations of enzyme activity in the diagnosis and follow-up of acute myocardial infarct].
    Preugschat R; Axthelm EH; Rehfeld N
    Z Med Lab Diagn; 1987; 28(1):47-8. PubMed ID: 3577325
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rationalization of serial determinations of enzyme activity in the diagnosis and follow-up of acute myocardial infarct].
    Peters JE; Liese W
    Z Med Lab Diagn; 1987; 28(1):45-6. PubMed ID: 3577324
    [No Abstract]   [Full Text] [Related]  

  • 40. [Enzyme markers in the calculation of the extent of infarction. Criteria of prognostic evaluation].
    Mayer MC; Russo V; Barretta G; Massari V; Costa A
    Minerva Cardioangiol; 1981 Sep; 29(9):441-9. PubMed ID: 7312170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.